Campath/Fludarabine/Melphalan Transplant Conditioning for Non-Malignant Diseases
Campath/Fludarabine/Melphalan Transplant Conditioning for Non-Malignant Diseases
Recruiting · NCT00920972 · Registry updated 2026-09-16Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Campath/Fludarabine/Melphalan Transplant Conditioning for Non-Malignant Diseases | Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Hemic and Lymphatic Diseases, Nutritional and Metabolic Diseases, hematologic disorder, hereditary disease, inherited hemoglobinopathy, metabolic disease | Recruiting | Phase 1 / Phase 2 | 2026-09-16 | NCT00920972 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| St. Louis Children's Hospital | 8 |
| Washington University School of Medicine | 475 |
28 results · Page 1 of 2
Research sites
Swipe the table sideways for more columns.